Lv1
90 积分 2024-06-18 加入
小干扰RNA药物在慢性病领域的研究新进展：从临床前到临床
3天前
已完结
高甘油三酯血症及其心血管风险管理专家共识
1个月前
已完结
Oral PCSK9 Inhibitors
1个月前
已完结
Drug discovery targeting thyroid hormone receptor β (THRβ) for the treatment of liver diseases and other medical indications
1个月前
已完结
Topical application of ketoconazole stimulates hair growth in C3H/HeN mice
1个月前
已完结
Thyroid receptor agonists for the treatment of androgenetic alopecia
2个月前
已完结
Gypenoside LVI improves hepatic LDL uptake by decreasing PCSK9 and upregulating LDLR expression
2个月前
已完结
Alirocumab boosts antioxidant status and halts inflammation in rat model of sepsis-induced nephrotoxicity via modulation of Nrf2/HO-1, PCSK9/HMGB1/NF-ᴋB/NLRP3 and Fractalkine/CX3CR1 hubs
2个月前
已完结
Novel and future lipid-modulating therapies for the prevention of cardiovascular disease
2个月前
已完结
Cholesterol ester transfer protein inhibition by TA-8995 in patients with mild dyslipidaemia (TULIP): a randomised, double-blind, placebo-controlled phase 2 trial
3个月前
已完结
皖公网安备34019202002308
